News

While identical twins have fingerprints that are more alike than those of unrelated individuals, they are still unique1, having formed prenatally by finger position, amniotic fluid dynamics, and chronicity (the number of placentas in multiple pregnancies). There is about 20% random development noise that produces this unique finding even among genetically identical twins.Fingerprints are a simple metaphor clinicians can use when explaining to patients why “but my twin doesn’t have this” isn’t...

Fully remote • 24–30 hours/week • $100/hour + GST Use your clinical skills, develop expertise in weight management and support patients across New Zealand, all from home. Pocket Lab is a New Zealand telehealth service helping patients nationwide. We’re looking for a Nurse Practitioner to join our online weight management team. You’ll work alongside our GP team, with all the required training and ongoing support provided. What’s on offer: ● Guaranteed regular hours ● Monday to...

Kia ora. Following significant consultation and engagement, Pharmac is making changes to the Pharmaceutical Schedule relating to antiretroviral medicines used in the treatment and prevention of HIV. What is changing Removal of Special Authority requirements: From 1 November 2026, there will no longer be a Special Authority requirement for funded antiretroviral treatment for any indication. The removal of Special Authority requirements is intended to reduce administrative burden. It does...

Please see below updates from Pharmac. Supply issue Pimafucort Ointment Pioglitazone tab 15 mg and tab 30 mg (Vexazone) Vannair Metered dose inhalers (budesonide/eformoterol) Brand change Coversyl tabs salt change Discontinuation Epilim tab 100 mg crushable date extended 1.Supply issue: Pimafucort Ointment There is an upcoming long-term supply issue affecting Pimafucort ointment. The supplier has advised that due to a significant manufacturing issue affecting an ingredient used in...

Pharmac has made changes to improve access to funded HIV medicines, making it easier for people living with HIV, or at risk of acquiring HIV, to access treatment when they need them. From 1 November 2026, people will no longer need to meet Special Authority or Hospital Restriction criteria to access funded antiretroviral medicines. We've also made two antiretroviral medicines, emtricitabine with tenofovir disoproxil and dolutegravir, available on a Practitioner's Supply Order (PSO) for...

Pharmac has made changes to improve access to funded HIV medicines, making it easier for people living with HIV, or at risk of acquiring HIV, to access treatment when they need them. From 1 November 2026, people will no longer need to meet Special Authority or Hospital Restriction criteria to access funded antiretroviral medicines. We've also made two antiretroviral medicines, emtricitabine with tenofovir disoproxil and dolutegravir, available on a Practitioner's Supply Order (PSO) for...